Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.7 |